Avalon Trust’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.3K Hold
200
﹤0.01% 378
2025
Q4
$19.2K Sell
200
-20
-9% -$1.94K ﹤0.01% 356
2025
Q3
$21K Buy
220
+20
+10% +$1.84K ﹤0.01% 390
2025
Q2
$17.4K Hold
200
﹤0.01% 327
2025
Q1
$18K Hold
200
﹤0.01% 335
2024
Q4
$16K Hold
200
﹤0.01% 301
2024
Q3
$18K Hold
200
﹤0.01% 268
2024
Q2
$15.7K Hold
200
﹤0.01% 272
2024
Q1
$17.4K Hold
200
﹤0.01% 278
2023
Q4
$16.5K Hold
200
﹤0.01% 280
2023
Q3
$15.7K Sell
200
-200
-50% -$16.7K ﹤0.01% 242
2023
Q2
$35.2K Hold
400
﹤0.01% 221
2023
Q1
$32.2K Buy
+400
New +$32.6K ﹤0.01% 221

Other funds holding MDT

Avalon Trust's MDT Position: Q1 2026 in Review

Avalon Trust held its Medtronic (MDT) position steady in Q1 2026 at 200 shares worth $17.3K. The position accounts for ﹤0.01% of the portfolio, ranked #378.

Avalon Trust first reported a position in MDT in Q1 2023 and has held it in 13 quarters since. The position peaked at $35.2K in Q2 2023. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Avalon Trust held 200 shares of Medtronic worth $17.3K as of Q1 2026.
  • Avalon Trust left its Medtronic share count unchanged in Q1 2026.
  • Medtronic made up ﹤0.01% of Avalon Trust's portfolio in Q1 2026, its #378 holding.
  • Avalon Trust first reported a position in Medtronic in Q1 2023 and has held it in 13 quarters since.
  • Avalon Trust's Medtronic position peaked at $35.2K in Q2 2023.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Avalon Trust's 13F filing for Q1 2026, filed 6 May 2026.